• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外化学敏感性试验在预测抗肿瘤药物对泌尿生殖系统肿瘤临床疗效中的作用。

The role of in vitro chemosensitivity tests to predict the clinical efficacy of antineoplastic agents in genito-urinary tumors.

作者信息

Türkeri L N, Akdaş G, Ozyürek M, Akdaş A

机构信息

Department of Urology, Ergun Ozalp Research Laboratory, Marmara University, School of Medicine Istanbul, Turkiye.

出版信息

Arch Esp Urol. 1998 May;51(4):398-404.

PMID:9656567
Abstract

OBJECTIVE

To develop an in vitro screening system to predict the response to treatment of common malignancies of the genito-urinary tract.

MATERIAL AND METHODS

Flow cytometric analysis and cytotoxicity assays (trypan blue and lactic dehydrogenase colorimetric tests) were performed on hormone resistant prostate cancer cell line PC-3 and primary transitional cell carcinoma samples treated with different antineoplastic agents and their combinations. Apoptosis induced by different agents was also investigated by previously established criteria.

RESULTS

There were 9 bladder tumors (47.4%) in the study group that displayed drug resistance to at least one antineoplastic agent. When the drugs were examined individually, there was resistance to cis-platinum in 3 patients (15.8%), methotrexate in 6 (31.6%), vinblastine in 7 (36.8%), epirubicin in 2 and adriamycin in 2 patients (10.5%). Stratification of patients according to the stage of the tumor revealed statistically significant difference between the superficial and invasive tumors in terms of drug resistance (p < 0.05). In prostate cancer cell line vinblastine treatment resulted in a significant increase in S phase fraction. Percent cytotoxicity by trypan blue exclusion test was 26.1% and was significantly higher than the control group (8.7%, p < 0.002). Also, an increase in apoptotic index after the treatment was observed (44.4% and 12.1%, respectively; p < 0.0001).

CONCLUSION

Both toxicity assays showed a very good correlation (p < 0.005) and can be used to evaluate the effects of different antineoplastic agents on individual tumors.

摘要

目的

开发一种体外筛选系统,以预测泌尿生殖道常见恶性肿瘤的治疗反应。

材料与方法

对激素抵抗性前列腺癌细胞系PC-3和经不同抗肿瘤药物及其组合处理的原发性移行细胞癌样本进行流式细胞术分析和细胞毒性测定(台盼蓝和乳酸脱氢酶比色试验)。还通过先前确立的标准研究了不同药物诱导的凋亡。

结果

研究组中有9例膀胱肿瘤(47.4%)对至少一种抗肿瘤药物表现出耐药性。单独检查药物时,3例患者(15.8%)对顺铂耐药,6例(31.6%)对甲氨蝶呤耐药,7例(36.8%)对长春碱耐药,2例对表柔比星耐药,2例对阿霉素耐药(10.5%)。根据肿瘤分期对患者进行分层显示,浅表性肿瘤和浸润性肿瘤在耐药性方面存在统计学显著差异(p<0.05)。在前列腺癌细胞系中,长春碱处理导致S期比例显著增加。通过台盼蓝排斥试验测得的细胞毒性百分比为26.1%,显著高于对照组(8.7%,p<0.002)。此外,观察到处理后凋亡指数增加(分别为44.4%和12.1%;p<0.0001)。

结论

两种毒性测定显示出非常好的相关性(p<0.005),可用于评估不同抗肿瘤药物对个体肿瘤的作用。

相似文献

1
The role of in vitro chemosensitivity tests to predict the clinical efficacy of antineoplastic agents in genito-urinary tumors.体外化学敏感性试验在预测抗肿瘤药物对泌尿生殖系统肿瘤临床疗效中的作用。
Arch Esp Urol. 1998 May;51(4):398-404.
2
In vitro chemosensitivity test for human genito-urinary tumors using collagen gel matrix.利用胶原凝胶基质对人泌尿生殖系统肿瘤进行体外化学敏感性试验。
Int J Urol. 2005 Jan;12(1):67-72. doi: 10.1111/j.1442-2042.2004.00985.x.
3
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.原发性国际妇产科联盟(FIGO)III期卵巢癌中药物反应与ATP肿瘤化疗敏感性检测的相关性
Gynecol Oncol. 2000 May;77(2):258-63. doi: 10.1006/gyno.2000.5728.
4
Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.辅助性甲氨蝶呤、长春碱、阿霉素和顺铂化疗有可能预防上尿路移行细胞癌手术切除后膀胱肿瘤的复发。
Int J Urol. 2008 Sep;15(9):800-3. doi: 10.1111/j.1442-2042.2008.02114.x. Epub 2008 Jul 10.
5
p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.p53免疫染色而非bcl-2免疫染色可预测乳腺癌患者对原发性化疗的临床完全缓解情况不佳。
Clin Cancer Res. 2000 Jul;6(7):2751-8.
6
[Chemosensitivity studies of urological malignancies].
Hinyokika Kiyo. 1988 Nov;34(11):1873-8.
7
Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.组织培养药物反应试验证明复发性乳腺癌中多药耐药性的获得。
Anticancer Res. 2001 Nov-Dec;21(6A):4083-6.
8
Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.上皮性卵巢癌患者中极端耐药性检测与对一线紫杉醇和顺铂反应之间的相关性
Gynecol Oncol. 1998 Sep;70(3):392-7. doi: 10.1006/gyno.1998.5109.
9
Pharmacodynamics of doxorubicin in human bladder tumors.阿霉素在人膀胱肿瘤中的药效学
Clin Cancer Res. 1996 Aug;2(8):1275-83.
10
Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.p53、bcl-2和Ki-67在高危浅表性膀胱癌中的预后意义
Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.